top of page

Welcome!
Captario was founded on a mission to empower pharmaceutical businesses to make more proactive, fast, and insightful decisions. With a vision of revolutionizing pharma decision-making, Captario's focus has consistently been on developing our proprietary SaaS platform, Captario SUM®, supported by in-house scientific research on portfolio optimization to meet the goal of finding a more precise and straightforward solution to drug development modeling.
6-Minute Demo of Captario SUM®
The Conference Team

John McClure
Head of Client Solutions

Anastasia Danopoulou
Senior Data Analyst

Shaineze Afir
Strategic Decision Lead Analyst

Stephanie Mardini
Key Account Manager
stephanie.mardini@captario.com

CASE STUDY
COVID-19 Portfolio Impact
Problem
A large pharma company with a robust clinical portfolio started seeing delays with no end to the COVID-19 pandemic in sight and wanted to understand the impact on portfolio value and risk.
Solution
Captario added delay scenarios in our system. Simulations were run with the delay across all projects set at 0, 3, 6, and 9 months and created a number of customized visualizations that specifically addressed the questions at hand.

bottom of page